{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:27:15Z","timestamp":1758587235705,"version":"3.44.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3150,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.virol.2004.09.010","type":"journal-article","created":{"date-parts":[[2004,10,15]],"date-time":"2004-10-15T11:21:09Z","timestamp":1097839269000},"page":"50-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of certain strains of HIV-1 by cell surface polyanions in the form of cholesterol-labeled oligonucleotides"],"prefix":"10.1016","volume":"330","author":[{"given":"Kwang-Soo","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2004.09.010_bib1","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1073\/pnas.86.20.7790","article-title":"Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues","volume":"86","author":"Agarwal","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2004.09.010_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/aid.1994.10.295","article-title":"A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects","volume":"10","author":"Aguilar-Cordova","year":"1994","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2004.09.010_bib3","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1073\/pnas.85.16.6132","article-title":"Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro","volume":"85","author":"Baba","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2004.09.010_bib4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2174\/0929867033457124","article-title":"Inhibiting HIV-1 entry with fusion inhibitors","volume":"10","author":"Baldwin","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.virol.2004.09.010_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0968-0004(03)00031-8","article-title":"Heparan sulfate proteoglycan as a plasma membrane carrier","volume":"28","author":"Belting","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.virol.2004.09.010_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/34571","article-title":"HIV-1 phenotypes classified by co-receptor usage","volume":"391","author":"Berger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.virol.2004.09.010_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/jvi.65.3.1543-1550.1991","article-title":"Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions","volume":"65","author":"Callahan","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2004.09.010_bib9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib10","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/nm1196-1244","article-title":"The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection","volume":"2","author":"Cocchi","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2004.09.010_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1993.1192","article-title":"Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate","volume":"193","author":"Compton","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.09.010_bib11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"Connor","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.09.010_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/aid.1996.12.281","article-title":"Soluble CD4 induces the binding of human immunodeficiency virus type 1 to cells via the V3 loop of glycoprotein 120 and specific sites in glycoprotein 41","volume":"12","author":"Demaria","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2004.09.010_bib14","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120","volume":"74","author":"Derdeyn","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/bc00012a007","article-title":"Effect of structural variations in cholesterol-conjugated oligonucleotides on inhibitory activity toward HIV-1","volume":"2","author":"Farooqui","year":"1991","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.virol.2004.09.010_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0042-6822(89)90448-0","article-title":"A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations","volume":"170","author":"Felser","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.09.010_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/jvi.69.2.834-839.1995","article-title":"A heterologous heparin-binding domain can promote functional attachment of a pseudorabies virus gC mutant to cell surfaces","volume":"69","author":"Flynn","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib18","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1128\/jvi.66.5.3183-3187.1992","article-title":"Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule","volume":"66","author":"Fouchier","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002030-199402000-00005","article-title":"Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding","volume":"8","author":"Harrop","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2004.09.010_bib20","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/jvi.69.11.6705-6711.1995","article-title":"Human immunodeficiency virus type I viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity","volume":"69","author":"He","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/096876899294760","article-title":"HIV-1 envelope determinants for cell tropism and chemokine receptor use","volume":"16","author":"Hoffman","year":"1999","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.virol.2004.09.010_bib22","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1073\/pnas.96.11.6359","article-title":"Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein","volume":"96","author":"Hoffman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2004.09.010_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.1636088","article-title":"Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1","volume":"257","author":"Hwang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.virol.2004.09.010_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-1702(99)00018-0","article-title":"Cell-surface heparan sulfate facilitates human immunodeficiency virus type 1 entry into some cell lines but not primary lymphocytes","volume":"60","author":"Ibrahim","year":"1999","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2004.09.010_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0166-3542(87)90018-0","article-title":"Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro","volume":"7","author":"Ito","year":"1987","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2004.09.010_bib26","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/JVI.73.3.1802-1808.1999","article-title":"The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system","volume":"73","author":"Kayman","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib27","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/JVI.76.4.1802-1815.2002","article-title":"Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus","volume":"76","author":"Kozak","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1073\/pnas.90.3.1048","article-title":"Modification of antisense phosphodiester oligodeoxynucleotides by a 5\u2032 cholesterol moiety increases cellular association and improves efficacy","volume":"90","author":"Krieg","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2004.09.010_bib29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.virol.2004.09.010_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/embo-reports\/kvd025","article-title":"Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection","volume":"1","author":"Manes","year":"2000","journal-title":"EMBO Rep."},{"key":"10.1016\/j.virol.2004.09.010_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/aid.1992.8.19","article-title":"Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro","volume":"8","author":"McClure","year":"1992","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2004.09.010_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.2452480","article-title":"Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells","volume":"240","author":"Mitsuya","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.virol.2004.09.010_bib34","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JVI.72.5.3623-3634.1998","article-title":"Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans","volume":"72","author":"Mondor","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib35","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/JVI.74.4.1948-1960.2000","article-title":"Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120","volume":"74","author":"Moulard","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1348-0421.1996.tb01148.x","article-title":"Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-I (HIV-1) infection","volume":"40","author":"Ohshiro","year":"1996","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.virol.2004.09.010_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/aid.1993.9.167","article-title":"Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines","volume":"9","author":"Patel","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2004.09.010_bib38","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1","volume":"72","author":"Plat","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib39","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1128\/JVI.76.10.4709-4722.2002","article-title":"Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells","volume":"76","author":"Popik","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib40","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1083\/jcb.148.5.997","article-title":"Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells","volume":"148","author":"Pralle","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.virol.2004.09.010_bib41","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.280.5370.1763","article-title":"A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding","volume":"280","author":"Rizzuto","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.virol.2004.09.010_bib42","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/jvi.69.4.2233-2239.1995","article-title":"Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120\u2013gp41","volume":"69","author":"Rodriguez","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/viro.2000.0431","article-title":"LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication","volume":"273","author":"Roos","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.09.010_bib44","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1093\/emboj\/18.23.6771","article-title":"Host cyclophilin A mediates HIV-1 attachment to target cells via heparans","volume":"18","author":"Saphire","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2004.09.010_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0042-6822(90)90440-3","article-title":"Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gf120 glycoprotein expressed by T-cells persistently infected wit HIV-1","volume":"175","author":"Schols","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.09.010_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/viro.2000.0780","article-title":"A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1","volume":"280","author":"Spenlehauer","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.09.010_bib47","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1021\/bi00223a020","article-title":"Mode of action of 5\u2032-linked cholesterol phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro","volume":"30","author":"Stein","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.virol.2004.09.010_bib48","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00253-003-1321-8","article-title":"Non-viral gene therapy: polycation-mediated DNA delivery","volume":"62","author":"Thomas","year":"2003","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.virol.2004.09.010_bib50","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1128\/JVI.73.11.8966-8974.1999","article-title":"A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor","volume":"73","author":"Trkola","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/viro.1997.8606","article-title":"Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses","volume":"233","author":"Vodicka","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.09.010_bib52","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) Monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2004.09.010_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/jvi.63.1.52-58.1989","article-title":"Initial interaction of herpes simplex virus with cells is binding to heparan sulfate","volume":"63","author":"Wudunn","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.09.010_bib54","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1128\/JVI.76.12.6332-6343.2002","article-title":"Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection","volume":"76","author":"Zhang","year":"2002","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682204005902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682204005902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:35:20Z","timestamp":1758584120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682204005902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0042682204005902"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2004.09.010","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of certain strains of HIV-1 by cell surface polyanions in the form of cholesterol-labeled oligonucleotides","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2004.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}